Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo

NCT03828149 is registered in ClinicalTrials.gov with Novus Therapeutics, Inc as lead sponsor.

NCT NCT03828149
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03828149 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo
Lead sponsor
Novus Therapeutics, Inc
Phase
Phase 1
Overall status
Completed
Start date
February 8, 2019
Completion date
March 7, 2019
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy adults